We are with you from day one, throughout your recovery. Braeburn is developing long-acting medicines for treating opioid addiction. Opioid addiction is a medical condition requiring medical treatment.

Dedicated to developing disease modifying therapies that improve survival, quality of life, and outcomes for patients with lung cancer, COPD, asthma, and other pulmonary diseases. With an initial focus on lung cancer diagnostics, Gala Therapeutics will build a portfolio of technologies to address the needs of Interventional Pulmonologists, Thoracic Surgeons, and all physicians who treat pulmonary disease.

Learn how to Raise Capital from Private Investors. Venture capital firms and funds in Europe. More Venture Capital Terms and Topics. DocuSign, It Is Official, Its Success Has Been Validated by the Market.

Bull; Fast and Complete Mapping. Bull; Non-contact Energy Delivery. Bull; Creation of Continuous Lesion Lines. Bull; Adjustable Ablation Depth. Bull; Improved Ease of Use. Bull; Faster Procedure Times. Bull; Fewer Repeat Procedures. Bull; Improved Safety Profile. Bull; Industry Veteran John Pavlidis Appointed As New VytronUS, Inc. Bull; VytronUS, Inc. 6 Million Series B Financing READ MORE.

Tumor suppressor p53 trimer and DNA fragment. Before a malignant tumor is developed, the immune system tries to fight against proteins that are altered during their formation, producing certain cancer antibodies. A biosensor developed by scientists from the Complutense University of Madrid. To verify their effectiveness, the researchers applied the developed biosensor to the analysis of serum samples from four patients with colorec.

The Biotech Venture Capital Podcast. Daily Digestif featuring Martin Lehr. He discussed his prior life at Osage University Partners. His current life at Context Therapeutics. And how his romantic life once dictated his professional life. Glen de Vries has his Head in the Cloud.